Melanoma Clinical Trial
Observational Study of Iris Tumors
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
Inclusion Criteria for tumor group:
Eyes with diagnosis of melanotic or amelanotic iris tumors
Inclusion Criteria for healthy control group:
Eyes without iris defects or lesions
Exclusion Criteria (both groups):
Inability to give informed consent
Inability to maintain stable fixation for OCT imaging
Inability to commit to required study visits
Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
Mature cataracts if found to limit visual potential to worse than 20/40
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.